The latest BHI Weekly E-Newsletter is live!
🔬 ARPA-H Takes on Rare Diseases: ARPA-H’s latest project aims to deliver hope and improved outcomes to millions of Americans with rare diseases.
💡 TEDCO Invests in Sonogen Medical Inc.: TEDCO announced a $200,000 investment in Sonogen Medical, a company developing ultrasonic bone fracture healing technology. This investment will propel their research towards an efficient, cost-effective solution.
👩⚕️ Women's Health Innovation Summit USA: Join ARPA-H Director Renee Wegrzyn, PhD, and other leaders to learn about the new $100M ARPA-H Sprint for Women’s Health Program and the White House Initiative on Women’s Health Research plans.
💰 BiomX Inc Announces Merger Agreement with Adaptive Phage Therapeutics: BiomX's merger with Adaptive Phage Therapeutics will create a phage therapy company with an advanced pipeline, backed by a $50 million financing.
🚀 Virginia Commonwealth University’s Startup Accelerator to Propel University Research: Virginia Commonwealth University launched its first formal Startup Accelerator program to fast-track emerging companies based on university research with market potential.
🌐 Council on Strategic Risks: National Security and Pharmaceutical Ingredients: The COVID-19 pandemic has highlighted the need for secure pharmaceutical supply chains. The Council on Strategic Risks explores the national security imperative to address overreliance on imports for active pharmaceutical ingredients.
Visit https://lnkd.in/e3K8pRi8 to read more.
Head of Federal Affairs and Policy at AstraZeneca
1moWhat an inspiring group of leaders, each playing an important role in advancing next generation science and medicine! 🌄